Migraine clinical trials at UCSD

2 in progress, 1 open to eligible people

Showing trials for

  • Children and Adolescents With Migraine: Acute Treatment

    open to eligible people ages 6-17

    The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

    La Jolla, California and other locations

  • Inhaled Cannabis for Acute Migraine Treatment

    Sorry, accepting new patients by invitation only

    This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.

    La Jolla, California

Our lead scientists for Migraine research studies include .

Last updated: